Home » Newsletters » BioWorld

BioWorld

June 4, 1993

View Archived Issues

FDA SETS UP NEW SYSTEM TO REPORT ADVERSE REACTIONS

APPOINTMENTS AND ADVANCEMENTS

PACT WITH MMD WORTH $17.5M TO SEPRACOR

UNIVAX FILES PLA

PROCORDIA TO FOCUS ON BIOTECH

THREE-WAY PCR DISPUTE RESOLVED

GERON RAISES $10.7M IN VENTURE FINANCING

BAXTER DISTRIBUTES STEM-CELL SELECTION SYSTEM

RHONE BUYS 37% OF AIS FOR $113M

CENTORX ENTERS PHASE III FOR ANGINA

$20 MILLION ALPHA-BETA PRIVATE PLACEMENT

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.